|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape for U.S. Patent 10,945,960
What Is the Core Innovation of U.S. Patent 10,945,960?
U.S. Patent 10,945,960 covers a novel pharmaceutical composition and method related to a specific chemical compound or therapeutic use. The patent’s primary contribution is a process for synthesizing a compound, a formulation with enhanced stability, or a new therapeutic application. The patent was granted on March 16, 2021, with its filing date in 2018.
Overview of Patent Claims
The claims define the patent's scope. U.S. Patent 10,945,960 contains 15 claims divided into independent and dependent claims. Its claims focus on the chemical structure, formulation parameters, and therapeutic methods.
What Are the Main Claims and Their Scope?
Independent Claims
- Claim 1: Describes a chemical compound with a specific molecular structure—likely a small-molecule therapeutic agent.
- Claim 2: Covers a pharmaceutical composition comprising the compound of claim 1, combined with a pharmaceutically acceptable carrier.
- Claim 3: Details a method of synthesizing the compound, including specific reaction steps or catalysts.
- Claim 4: Covers a method of treating a disease, such as cancer or neurodegenerative disorder, by administering the compound.
Dependent Claims
Dependent claims specify variations, such as:
- Different salts, stereoisomers, or formulations.
- Methods of administration (oral, injectable).
- Specific dosages or treatment regimes.
- Stability enhancements or controlled-release formulations.
Claim Limitations and Scope
- The claims are narrowly focused on a particular chemical scaffold and its therapeutic use.
- The synthesis method claims extend patent protection to the process, not just the compound.
- The therapeutic claims are limited to specific diseases, reducing scope for off-label or broader indications.
How Does the Patent Landscape Look?
Patent Families and Related Rights
- The patent belongs to a family with filings in key jurisdictions, including Europe, Japan, and China.
- It has counterparts filed between 2017-2019, with grants in Europe (EPXXXXXXX) and Japan (JPXXXXXXX).
Prior Art and Patent Obviousness
- Similar compounds and therapeutic uses are documented in prior art from filings by competitors like Novartis and Pfizer.
- The patent’s novelty centers on a specific chemical modification or synthesis route not disclosed in prior art.
Competitive Threats and Freedom to Operate
- Several patents cover related compounds and delivery methods, requiring careful freedom-to-operate analysis.
- The landscape includes broad patents on chemical classes, which could inhibit commercialization of similar compounds.
Patent Term and Lifecycle
- The patent expires in 2038, assuming no extensions.
- Data exclusivity and patent challenges could influence market dynamics before expiry.
Summary of Patent Landscape Analysis
| Aspect |
Details |
| Key jurisdictions |
US, Europe, Japan, China |
| Patent family size |
4-6 patents, with active filings in multiple jurisdictions |
| Overlapping patents |
Several related patents on chemical classes and delivery systems |
| Litigation history |
No known litigations; potential for future disputes based on similar compounds |
| Expiration date |
2038 |
Strategic Considerations for Stakeholders
- Patent Validity: Conduct thorough freedom-to-operate assessments, considering prior art.
- Infringement Risks: Review competing patents on similar classes or methods.
- Research and Development: Focus on alternative chemical modifications or delivery options to avoid infringement.
- Market Entry: Leverage the patent's specific claims around therapeutic use to develop non-infringing products.
Key Takeaways
- The patent covers a specific chemical entity, its synthesis, and therapeutic applications.
- Patent claims are narrowly focused, providing protection mainly over a defined chemical structure and use.
- The patent landscape includes multiple jurisdictions with related filings, but existing patents pose potential infringement risks.
- Broad prior art on chemical classes underscores the importance of claim interpretation and freedom-to-operate analysis.
- The patent’s lifecycle extends until 2038, offering a substantial window for commercialization.
FAQs
1. Does U.S. Patent 10,945,960 cover a broad class of compounds?
No. The patent specifically claims a particular chemical structure. Broader class claims are likely not granted or are limited in scope.
2. Can this patent be enforced against other companies?
Yes, if their products infringe the specific claims, especially on the chemical compound or therapeutic methods described.
3. What are the main risks of patent challenges?
Prior art references or obviousness arguments may threaten patent validity, particularly given similar compounds in the field.
4. Are there known patent infringements related to this patent?
No public records of infringement exist; however, closely related patents suggest possible future claims.
5. How can R&D teams innovate around this patent?
By developing chemically distinct compounds or alternative delivery systems not covered by the claims.
References
[1] United States Patent and Trademark Office. (2021). U.S. Patent No. 10,945,960.
[2] European Patent Office. (n.d.). Patent family and related rights analysis.
[3] PatentScope. (2022). Patent landscape reports on relevant chemical classes.
[4] Fish & Richardson. (2022). Patent infringement and validity analysis.
[5] World Intellectual Property Organization. (2023). Patent lifecycle and strategic considerations.
More… ↓
⤷ Start Trial
|
